Core Laboratories Inc. $CLB Shares Acquired by UBS Group AG

UBS Group AG boosted its stake in Core Laboratories Inc. (NYSE:CLB) by 32.9% during the 4th quarter, HoldingsChannel.com reports. The fund owned 412,515 shares of the oil and gas company’s stock after purchasing an additional 102,151 shares during the period. UBS Group AG’s holdings in Core Laboratories were worth $6,613,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors have also recently added to or reduced their stakes in the stock. CWA Asset Management Group LLC purchased a new stake in Core Laboratories in the 4th quarter valued at approximately $9,978,000. Disciplined Growth Investors Inc. MN boosted its holdings in Core Laboratories by 9.7% in the 3rd quarter. Disciplined Growth Investors Inc. MN now owns 5,969,860 shares of the oil and gas company’s stock valued at $73,787,000 after purchasing an additional 528,976 shares in the last quarter. Bank of America Corp DE boosted its holdings in Core Laboratories by 48.1% in the 3rd quarter. Bank of America Corp DE now owns 343,340 shares of the oil and gas company’s stock valued at $4,244,000 after purchasing an additional 111,527 shares in the last quarter. Hotchkis & Wiley Capital Management LLC boosted its holdings in Core Laboratories by 22.2% in the 3rd quarter. Hotchkis & Wiley Capital Management LLC now owns 559,625 shares of the oil and gas company’s stock valued at $6,917,000 after purchasing an additional 101,755 shares in the last quarter. Finally, BNP Paribas Financial Markets boosted its holdings in Core Laboratories by 1,667.2% in the 3rd quarter. BNP Paribas Financial Markets now owns 79,628 shares of the oil and gas company’s stock valued at $984,000 after purchasing an additional 75,122 shares in the last quarter. Institutional investors and hedge funds own 97.81% of the company’s stock.

Core Laboratories Price Performance

CLB stock opened at $13.72 on Wednesday. Core Laboratories Inc. has a 1 year low of $9.72 and a 1 year high of $20.36. The company has a debt-to-equity ratio of 0.42, a quick ratio of 1.50 and a current ratio of 2.05. The stock’s 50 day moving average price is $15.83 and its 200 day moving average price is $16.71. The firm has a market cap of $632.26 million, a P/E ratio of 21.10, a PEG ratio of 2.69 and a beta of 0.99.

Core Laboratories (NYSE:CLB) last posted its earnings results on Wednesday, April 29th. The oil and gas company reported $0.06 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.06. Core Laboratories had a return on equity of 11.52% and a net margin of 5.94%.The firm had revenue of $121.80 million for the quarter, compared to analyst estimates of $122.99 million. During the same quarter in the prior year, the company earned $0.14 EPS. Core Laboratories’s revenue was down 1.4% on a year-over-year basis. Core Laboratories has set its Q2 2026 guidance at 0.060-0.120 EPS. On average, sell-side analysts expect that Core Laboratories Inc. will post 0.54 earnings per share for the current fiscal year.

Core Laboratories Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Monday, June 1st. Investors of record on Monday, May 11th will be paid a $0.01 dividend. The ex-dividend date of this dividend is Monday, May 11th. This represents a $0.04 dividend on an annualized basis and a yield of 0.3%. Core Laboratories’s dividend payout ratio is presently 6.15%.

Analysts Set New Price Targets

Several equities research analysts have recently commented on the company. Weiss Ratings lowered Core Laboratories from a “hold (c)” rating to a “hold (c-)” rating in a research note on Monday, May 4th. Wall Street Zen raised Core Laboratories from a “sell” rating to a “hold” rating in a research note on Sunday. Three equities research analysts have rated the stock with a Hold rating, According to data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus target price of $12.00.

Core Laboratories Company Profile

Core Laboratories N.V. is a global provider of proprietary and patented reservoir description and production enhancement services to the oil and gas industry. The company applies specialized expertise in core and fluid analysis, advanced petrophysical interpretation, and reservoir engineering to optimize hydrocarbon recovery. By integrating laboratory testing with field services and digital analytics, Core Laboratories delivers insights that help operators maximize production and extend the life of their assets.

The company’s portfolio spans two primary service lines: reservoir description and production enhancement.